Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Investigating the link between pain sensitivity and cognitive issues in fibromyalgia patients

Official title: Investigation of the Relationship Between Central Sensitization Symptoms and Cognitive Dysfunction in Patients With Fibromyalgia

Run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · NCT06948903 · Data updated 2026-11-12

This study is trying to see how pain sensitivity affects thinking problems in people with fibromyalgia.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Academic / other
Locations1 site (Istanbul, Uskudar)
StatusRecruiting
StartedJanuary 10, 2023
Main results expectedAugust 1, 2025
Study endsOctober 1, 2025
Registry record updatedSeptember 12, 2025
Trial IDNCT06948903 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-65 who have been diagnosed with fibromyalgia according to the American College of Rheumatology criteria.

Probably not a fit

Patients with concurrent systemic inflammatory diseases, central nervous system diseases, or other conditions that may lead to cognitive impairment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore how central sensitization symptoms influence cognitive dysfunction in individuals diagnosed with fibromyalgia. It seeks to determine the extent of this relationship and how cognitive complaints correlate with other clinical parameters, including disease severity. The study employs various assessments such as the Central Sensitization Inventory and the Montreal Cognitive Assessment to gather data on participants. By understanding these connections, the research hopes to shed light on the complexities of fibromyalgia and its impact on cognitive function.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of cognitive dysfunction in fibromyalgia patients.

How similar studies have gone: While studies have explored aspects of central sensitization and cognitive dysfunction, this specific investigation into their relationship in fibromyalgia is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being diagnosed with fibromyalgia according to American College of Rheumatology 2016 criteria
* Being between 18-65 years old
* Being literate
* Accepting to participate in the study

Exclusion Criteria:

* Concomitant systemic inflammatory disease, central nervous system disease (cortical involvement), active infection and malignancy history
* History of illness that may lead to cognitive impairment
* Being \<18 and \>65 years old
* Being illiterate
* Not accepting to participate in the study

Where it's running

  • Health Sciences University
    Istanbul, Uskudar, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.